Author:
Kone-Paut Isabelle, ,Barete Stéphane,Bodaghi Bahram,Deiva Kumaran,Desbois Anne-Claire,Galeotti Caroline,Gaudric Julien,Kaplanski Gilles,Mahr Alfred,Noel Nicolas,Piram Maryam,Tran Tu-Anh,Wechsler Bertrand,Saadoun David
Abstract
AbstractBehçet’s disease (BD) is a systemic variable vessel vasculitis that involves the skin, mucosa, joints, eyes, arteries, veins, nervous system and gastrointestinal system, presenting with remissions and exacerbations. It is a multifactorial disease, and several triggering factors including oral cavity infections and viruses may induce inflammatory attacks in genetically susceptible individuals. BD vasculitis involves different vessel types and sizes of the vascular tree with mixed-cellular perivascular infiltrates and is often complicated by recurrent thrombosis, particularly in the venous compartment. Several new therapeutic modalities with different mechanisms of action have been studied in patients with BD. A substantial amount of new data have been published on the management of BD, especially with biologics, over the last years. These important therapeutic advances in BD have led us to propose French recommendations for the management of Behçet’s disease [Protocole National de Diagnostic et de Soins de la maladie de Behçet (PNDS)]. These recommendations are divided into two parts: (1) the diagnostic process and initial assessment; (2) the therapeutic management. Thirty key points summarize the essence of the recommendations.
We highlighted the main differential diagnosis of BD according to the type of clinical involvement; the role of genetics is also discussed, and we indicate the clinical presentations that must lead to the search for a genetic cause.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference66 articles.
1. Akman-Demir G, Bahar S, Coban O, Tasci B, Serdaroglu P. Cranial MRI in Behçet’s disease: 134 examinations of 98 patients. Neuroradiology. 2003;45(12):851–9.
2. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain J Neurol. 1999;122(Pt 11):2171–82.
3. Atmaca L, Boyvat A, Yalçındağ FN, Atmaca-Sonmez P, Gurler A. Behçet disease in children. Ocul Immunol Inflamm. 2011;19(2):103–7.
4. Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S. The performance of different classification criteria in paediatric Behçet’s disease. Clin Exp Rheumatol. 2017;35 Suppl 108(6):119–23.
5. Benamour S, Naji T, Alaoui F-Z, El-Kabli H, El-Aidouni S. Neurological involvement in Behçet’s disease. 154 cases from a cohort of 925 patients and review of the literature. Rev Neurol (Paris). 2006;162(11):1084–90.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献